| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2017 | Emster Kurt Von62 | Director | Sell | 3,150 | $18.52 | $58,344.50 | - | |
| Aug 17, 2017 | Emster Kurt Von62 | Director | Sell | 34,141 | $19.06 | $650,692.78 | -0.8% | |
| Aug 15, 2017 | Emster Kurt Von62 | Director | Sell | 55,569 | $19.59 | $1,088,560.70 | -1.3% | |
| Aug 8, 2017 | Emster Kurt Von62 | Director | Sell | 35,473 | $18.63 | $660,887.69 | -0.8% | |
| Aug 8, 2017 | Dylan-Hyde Tyler | Chief Legal Officer | Sell | 15,000 | $18.57 | $278,479.19 | -3.1% | |
| Aug 4, 2017 | Emster Kurt Von62 | Director | Sell | 50,477 | $17.81 | $899,215.93 | -1.1% | |
| Aug 1, 2017 | Emster Kurt Von62 | Director | Sell | 5,512 | $17.51 | $96,491.49 | -0.1% | |
| Jul 28, 2017 | Emster Kurt Von62 | Director | Sell | 41,312 | $17.63 | $728,134.00 | -0.9% | |
| Jul 26, 2017 | Emster Kurt Von62 | Director | Sell | 32,930 | $17.60 | $579,545.44 | -0.7% | |
| Jul 14, 2017 | Emster Kurt Von62 | Director | Sell | 69,859 | $16.84 | $1,176,709.83 | -1.4% |